GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (FRA:8NN) » Definitions » Short Percentage of Float

Thor Medical ASA (FRA:8NN) Short Percentage of Float


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Thor Medical ASA's Short Percentage of Float

For the Biotechnology subindustry, Thor Medical ASA's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Short Percentage of Float falls into.


;
;

Thor Medical ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (FRA:8NN) » Definitions » Short Percentage of Float
Comparable Companies
OSL:NYKD OSL:HBC OSL:AZT OSL:LYTIX OSL:ZLNA OSL:SOFTX OSL:EXTX OSL:ONCIN OSL:ABS OSL:ABTEC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
TRMED:Norway 0R6Y:UK
Address
Karenslyst Alle 9C, Oslo, NOR, 0278
Website
https://www.thormedical.no
Thor Medical ASA is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells.

Thor Medical ASA Headlines

No Headlines